¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Abnormal findings in cerebrospinal fluid"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • aqueous fluid
    ¹æ¼ö
  • ascitic fluid
    º¹¼ö
  • air fluid level
    °ø±â¾×üÃþ
  • allantoic fluid
    ¿ä¸·°ø°£¾×, ¿ä¸·°­¾×
  • amniotic fluid
    ¾ç¼ö
  • amniotic fluid index
    ¾ç¼öÁö¼ö
  • body fluid
    ü¾×
  • body fluid compartment
    ü¾×±¸È¹
  • culture fluid
    ¹è¾ç¾×
  • excessive fluid retention
    °úÀ×¾×üÀÜ·ù
  • extracellular fluid
    ¼¼Æ÷¹Ù±ù¾×, ¼¼Æ÷¿Ü¾×
  • extravascular fluid
    Ç÷°ü¿Ü¾×
  • exuvial fluid
    Å»ÇǾ×, Çã¹°¾×
  • fluid
    1. ¾×, ¾×ü 2. ü¾× 3. ¼ö¾×, ¼ö
  • fluid attenuated inversion recovery
    ¾×ü°¨¼è¿ªÀüȸº¹
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • abnormal retinal correspondence
    ÀÌ»ó¸Á¸·´ëÀÀ
  • abnormal uterine bleeding
    ÀÌ»óÀÚ±ÃÃâÇ÷
  • subtotal abnormal shape
    ºÎºÐÀÌ»óÇüÅÂ
  • air fluid level
    °ø±â¾×üÃþ
  • air-fluid exchange
    °ø±â¾×ü±³È¯(¼ú)
  • allantoic fluid
    ¿ä¸·°ø°£¾×, ¿ä¸·¾×
  • amniotic fluid
    ¾ç¼ö
  • aqueous fluid
    ¹æ¼ö
  • ascitic fluid
    º¹¼ö
  • body fluid
    ü¾×
  • body fluid compartment
    ü¾×±¸È¹, ü¾×±¸ºÐ
  • fluid balance
    ü¾×ÆòÇü
  • culture fluid
    ¹è¾ç¾×
  • fluid culture
    ¾×ü¹è¾ç
  • fluid velocity curve
    À¯¼Ó°î¼±
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • abnormal retinal correspondance
    ÀÌ»ó¸Á¸·´ëÀÀ
  • abnormal shape
    ÀÌ»óÇüÅÂ
  • abnormal temperature
    ÀÌ»ó¿Âµµ, ÀÌ»óü¿Â(~ü¿Â).
  • abnormal uterine bleeding
    ÀÌ»óÀÚ±ÃÃâÇ÷(~í­Ïàõóúì).
  • abocclusion =abnormal occlusion
    °³±³(ËÒÎá).
  • hemoglobinopathy =abnormal hemoglobin disease
    Ç÷»ö¼Òº´Áõ.
  • Champys fixing fluid
    ¼§ÇǰíÁ¤¾×.
  • FLAIR(fluid attenuated inversion recovery)
    ¾×ü °¨¾à ¹ÝÀü ȸº¹
  • Fluid compartments
    ü¾×±¸¿ª(ô÷äûÏ¡æ´)
  • Fluid volumes, body, measurement of 1-2
    ü¾×(ô÷äû)ºÎÇÇ, ÃøÁ¤(ö´ïï)
  • Hyperosmotic fluid
    °í»ïÅõ¼º¿ë¾×(ÍÔß¶÷âàõéÁäû)
  • Hypertonic fluid
    °íÀ强¿ë¾×(ÍÔíåàõéÁäû)
  • Hypo-osmotic fluid
    Àú»ïÅõ¿ë¾×(î¸ß¶÷âéÁäû)
  • Hypotonic fluid
    ÀúÀ强¿ë¾×(î¸íåàõéÁäû)
  • ISF= interstitial fluid
    °£Áú¾×(Êàòõäû).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • rhinorrhea, cerebrospinal fluid
    (³úô)¼ö¾×ºñ·ç
  • examination findings
    °Ë»ç¼Ò°ß.
  • normal findings
    Á¤»ó¼Ò°ß(ïáßÈá¶úæ)
  • percussion findings
    ŸÁø¼Ò°ß(¡­á¶úæ).
  • fluid fluid level
    ¾×ü ¾×ü Ãþ
  • abnormal behavior
    ÀÌ»óÇൿ(~ú¼ÔÑ).
  • abnormal bite =occlusion
    ÀÌ»ó±³ÇÕ
  • abnormal child
    ºñÁ¤»ó¾Æ(ÞªïáßÈä®).
  • abnormal echo
    ºñÁ¤»ó (ÞªïáßÈ) ¿¡ÄÚ, ºñÁ¤»ó (ÞªïáßÈ) ¸Þ¾Æ¸®
  • abnormal fusion
    ºñÁ¤»óÀ¶ÇÕ
  • abnormal growth
    ºñÁ¤»ó¼ºÀå
  • abnormal hemoglobin
    ÀÌ»óÇ÷»ö¼Ò(~Ì´Ë×ËÛ), ÀÌ»óÇì¸ð±Û·Îºó.
  • abnormal localization of immature precursor cells=ALIP
    ¹Ì¼º¼÷Àü±¸¼¼Æ÷ÀÇ ºñÁ¤»ó ±¹Àç
  • abnormal movements
    ÀÌ»ó¿îµ¿(ì¶ßÈê¡ÔÑ).
  • abnormal patency of the eustachian tube
    À̰ü°³¹æÁõ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • intracellular fluid
    ¼¼Æ÷³» ü¾×
  • joint fluid
    Ȱ¾×, °üÀý¾×
  • pericardial fluid
    ½É¸·¾×
  • pleural fluid
    Èä¼ö
  • serous fluid
    Àå¾×
  • spinal fluid
    ô¼ö¾×
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
NAD neutrophil actin dysfunction; new antigenic determinant; nicotinamide adenine dinucleotide; nicotini...
FR failure rate; film-screen radiograph; fasciculus retroflexus; febrile reaction; feedback regulation;...
ACSF artificial cerebrospinal fluid
BCB blood-cerebrospinal fluid barrier; brilliant cresyl blue
CFVS cerebrospinal fluid flow void sign
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AIM abnormal involuntary movement
AUB Abnormal Uterine Bleeding
Awd Abnormal wing disc
CSF Cerebrospinal
TAM Transient abnormal myelopoiesis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • abnormal jaw closure
    ÀÌ»ó ¾Ç°ñ ±³ÇÕ, ¾Ç°ñ ±³ÇÕ ÀÌ»ó
    ¼Ò±¸Ä¡¿Í ´ë±¸Ä¡ÀÇ ±³ÇÕ¸éÀ̳ª ¹Ý´ëÆí ±³ÇÕ¸éÀÇ Á¢ÃËÀÌ Á¤»óÀ» ¹þ¾î³ª´Â °æ¿ì.
  • abnormal laterality syndrome
    ÁÂ¿ì ºñ´ëĪ ÀÌ»ó ÁõÈıº
    ½ÉÀå¿¡¼­ Á¤»óÀûÀÎ ÁÂ¿ì ´ëĪÀÌ µÚ¹Ù²î°Å³ª ºÒ¿ÏÀüÇÑ °æ¿ì·Î¼­, ÁÂÃøÀ̳ª ¿ìÃøÇüÀ¸·Î ´ëĪÀÎ °æ¿ì°¡ ÀÖ°í À̵鿡¼­ ¿©·¯ °¡Áö ½ÉÀå ±âÇüÀÌ µ¿¹ÝµÇ´Âµ¥ ÀÌ·¯ÇÑ °æ¿ì¸¦ ½ÉÀåÀÇ ÁÂ¿ì ºñ´ëĪ ÀÌ»ó ÁõÈıºÀ̶ó ÇÑ´Ù. À̵é Áúȯ¿¡¼­´Â ½ÉÀå »Ó ¾Æ´Ï¶ó ÁÖ ±â°üÁö¿Í »óÆóµ¿¸ÆÀÇ À§Ä¡ °ü°è ¹× ÆóÀÇ ºÐ¿±, °£°ú ºñÀåÀÇ ÇüÅ ¹× À§Ä¡°¡ ´Þ¶óÁö¸ç ƯÈ÷ ºñÀåÀÌ ¾ø´Â ¹«ºñÁõ
  • abnormal liquid
    ºñÁ¤»ó ¾×ü
  • abnormal movement
    ºñÁ¤»óÀû ¿îµ¿, ÀÌ»ó ¿îµ¿
    »óÇÏ¾Ç Ä¡¿­ ¹× ±³ÇÕÀÌ Á¤»óÀ» ¹þ¾î³ª ¾î±ß³­ »óÅ·ΠÇϾÇÀÌ ¿òÁ÷ÀÌ´Â °Í.
  • abnormal occlusal wear
    ºñÁ¤»ó ±³¸ð, ºñÁ¤»óÀûÀÎ ±³¸ð
    »óÇÏ¾Ç Ä¡¾ÆÀÇ ¸¶Âû·Î ÀÎÇØ ÀϾ´Â Á¤»óÀûÀÎ ±³¸ðº¸´Ù ´õ ¸¹ÀÌ ´â°Å³ª Àû°Ô ´â´Â °æ¿ì·Î¼­ ´ëºÎºÐ Á¤»óº¸´Ù ´õ ¸¹ÀÌ ´â´Â °æ¿ì¸¦ ÀǹÌÇÑ´Ù.
  • abnormal position
    À§Ä¡ ÀÌ»ó
    Á¤»óÀûÀÎ À§Ä¡¿¡¼­ ¹þ¾î³­ »óÅÂ. Á¶Á÷ÀÌ ÀÖ¾î¾ß ÇÒ À§Ä¡¿¡¼­ ¹þ¾î³­ »óÅÂ.
  • abnormal protein
    ºñÁ¤»ó ´Ü¹éÁú
  • abnormal quality
    ºñÁ¤»óÀûÀÎ ¼ºÁú
    Á¤»ó¿¡¼­ ¹þ¾î³­ ¼ºÁú.
  • abnormal regeneration
    ºñÁ¤»ó Àç»ý
    Á¶Á÷ÀÇ Àç»ýÀÌ Á¤»óÀûÀÎ »óÅÂ¿Í ´Ù¸£°Ô ÀϾ´Â °Í.
  • abnormal root
    ÀÌ»ó Ä¡±Ù
    Ä¡±ÙÀÇ Çüųª ¼ö¿¡ ÀÌ»óÀÌ ÀÖ´Â °æ¿ì. À̻󽺷´°Ô ±æ°Å³ª ªÀº ±¼°î±Ù, °úÀ×±Ù, ºÎ±Ù, ½Ö»ý±Ù µîÀÌ ÀÖ´Ù.
  • abnormal swallowing
    ºñÁ¤»óÀû ¿¬ÇÏ
    ÀÚ¿¬½º·´Áö ¸øÇÑ ¿¬ÇÏ. À½½ÄÀ» »ïų ¶§ ÀϾ´Â Çô¿Í ±¸°­ Á¶Á÷ÀÇ ¿îµ¿ÀÌ Á¤»óÀûÀÎÁö ¾ÊÀº »óÅÂ.
  • abnormal tooth wear
    ÀÌ»ó Ä¡¾Æ ¸¶¸ð, ºñÁ¤»óÀûÀÎ Ä¡¾Æ ¸¶¸ð
    ºñÁ¤»óÀûÀÎ ±â´É¿¡ ÀÇÇÑ Ä¡¾Æ ¸¶¸ð Çö»ó.
  • abnormal uterine bleeding
    ÀÌ»ó Àڱà ÃâÇ÷
    ÀÚ±ÃÀ¸·ÎºÎÅÍ Çǰ¡ ºñÁ¤»óÀûÀ¸·Î ³ª¿À´Â °Í. ¿ù°æÀÇ °æ¿ì¸¦ Á¦¿ÜÇϰí´Â ºñÁ¤»ó ÃâÇ÷·Î »ý°¢ÇÒ ¼ö ÀÖ´Ù.
  • amniotic fluid embolism
    ¾ç¼ö »öÀüÁõ
    ºÐ¸¸ ½Ã¿Í ºÐ¸¸ Á÷ÈÄ¿¡ ¹ß»ýÇÏ´Â Áö±ØÈ÷ ÁßÇÑ ÇÕº´ÁõÀ¸·Î½á ÃâÇ÷, µ¶Ç÷Áõ, Æó»öÀüÁõ°ú °°Àº Ä¡¸íÀûÀÎ ÇÕº´Áõ°ú ÇÔ²² »ê¸ð »ç¸ÁÀÇ ÁÖ¿ä ¿øÀÎÀÌ µÇ°í ÀÖ´Ù. 5¸¸¸í Áß 1¸í²Ã·Î ¹ß»ýÇϸç 89%ÀÇ »ç¸Á·üÀ» º¸ÀδÙ.
  • bleaching fluid
    Ç¥¹é ¾×
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
haemoglobins, abnormal Haemoglobins altered in their genetically determined molecular structure, resulting in a characteristic complex of vlinival and laboratory abnormalities. The specific features of the abnormal haemoglobins are related to variation of the composite globin polypeptide chains.
(12 Dec 1998)
pupillary functions, abnormal Conditions in which the pupil does not react normally to dilation and constriction. Signs of pupillary abnormalities originate from the pupil's shape, position, and response to stimulation.
(12 Dec 1998)
fibrinogens, abnormal Fibrinogens which have a functional defect as the result of one or more amino acid substitutions in the amino acid sequence of normal fibrinogen. Abnormalities of the fibrinogen molecule may impair any of the major steps involved in the conversion of fibrinogen into stabilised fibrin, such as cleavage of the fibrinopeptides by thrombin, polymerization and cross-linking of fibrin. The resulting dysfibrinogenaemias can be clinically silent or can be associated with bleeding, thrombosis or defective wound healing.
(12 Dec 1998)
cerebrospinal <anatomy> Pertaining to the brain and spinal cord.
(18 Nov 1997)
cerebrospinal axis The central nervous system; the brain and spinal cord.
Synonym: encephalomyelonic axis, neural axis.
(05 Mar 2000)
cerebrospinal fever An acute infectious disease affecting children and young adults, caused by Neisseria meningitidis; characterised by nasopharyngeal catarrh, headache, vomiting, convulsions, stiffness in the neck (nuchal rigidity), photophobia, constipation, cutaneous hyperesthesia, a purpuric or herpetic eruption, and the presence of Kernig's sign. Fulminant form may cause Waterhouse-Friderichsen syndrome.
Synonym: cerebrospinal fever, epidemic cerebrospinal meningitis.
(05 Mar 2000)
cerebrospinal index The figure obtained by multiplying the pressure of the cerebrospinal fluid, after fluid has been withdrawn by spinal puncture, by the quantity of fluid withdrawn and then dividing by the original pressure.
Synonym: cephalorrhachidian index.
(05 Mar 2000)
cerebrospinal meningitis <microbiology, neurology> Inflammation of the meninges. When it affects the dura mater, the disease is termed pachymeningitis, when the arachnoid and pia mater are involved, it is called leptomeningitis or meningitis proper.
See also: aseptic meningitis.
Origin: Gr. Meninx = membrane
(21 Jun 1999)
cerebrospinal nematodiasis Invasion of the central nervous system by wandering nematode larvae; e.g., Setaria species in horses, Angiostrongylus cantonensis in rats and humans.
(05 Mar 2000)
cerebrospinal otorrhoea Discharge of cerebrospinal fluid through the external auditory meatus or through the eustachian tube into the nasopharynx.
(12 Dec 1998)
cerebrospinal pressure The pressure of the cerebrospinal fluid, normally 100 to 150 mm of water, relative to the ambient atmospheric pressure.
(05 Mar 2000)
cerebrospinal rhinorrhoea Discharge of cerebrospinal fluid through the nose.
(12 Dec 1998)
cerebrospinal system The combined central nervous system and peripheral nervous system.
(05 Mar 2000)
epidemic cerebrospinal meningitis An acute infectious disease affecting children and young adults, caused by Neisseria meningitidis; characterised by nasopharyngeal catarrh, headache, vomiting, convulsions, stiffness in the neck (nuchal rigidity), photophobia, constipation, cutaneous hyperesthesia, a purpuric or herpetic eruption, and the presence of Kernig's sign. Fulminant form may cause Waterhouse-Friderichsen syndrome.
Synonym: cerebrospinal fever, epidemic cerebrospinal meningitis.
(05 Mar 2000)
allantoic fluid The fluid within the allantoic cavity.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fluid mechanics
    À¯Ã¼¿ªÇÐ
  • fluid ounce
    ¾×·® ¿Â½º
  • fluid power
    À¯Ã¼µ¿·Â
  • fluid pressure
    À¯Ã¼ ¾Ð·Â;À¯¾Ð
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á